Currency In USD
| Previous Close | 3.11 |
| Open | 3.19 |
| Day High | 3.19 |
| Day Low | 3.03 |
| 52-Week High | 15.55 |
| 52-Week Low | 2.77 |
| Volume | 2.12M |
| Average Volume | 2.16M |
| Market Cap | 179.76M |
| PE | 1.6 |
| EPS | 1.89 |
| Moving Average 50 Days | 5.43 |
| Moving Average 200 Days | 10.44 |
| Change | -0.08 |
embecta names new Chairman of the Board and Lead Independent Director
GlobeNewswire Inc.
Feb 11, 2026 9:10 PM GMT
PARSIPPANY, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that the Boar
Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results
GlobeNewswire Inc.
Feb 05, 2026 11:30 AM GMT
PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter
embecta to Report Fiscal First Quarter Financial Results
GlobeNewswire Inc.
Jan 22, 2026 10:00 PM GMT
PARSIPPANY, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call t